Related Experiment Videos
Molecular pathogenesis of thyroid cancer
Dorry L Segev1, Christopher Umbricht, Martha A Zeiger
1Department of Surgery, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Surgical Oncology
|August 30, 2003
Summary
Molecular changes drive thyroid cancer progression from normal tissue to anaplastic carcinoma. This study evaluates factors in thyroid tumorigenesis, proposing a molecular progression model for follicular thyroid cancers.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Thyroid cancer development involves molecular abnormalities.
- Progression from normal tissue to anaplastic carcinoma is linked to genetic and cellular changes.
- Upregulation of growth factors and oncogenes, and downregulation of tumor suppressors are implicated.
Purpose of the Study:
- To comprehensively evaluate factors involved in thyroid tumorigenesis.
- To propose a preliminary molecular progression model for thyroid cancer.
- To provide a framework for integrating future genomic data.
Main Methods:
- Review and synthesis of existing literature on thyroid cancer molecular pathology.
- Analysis of molecular alterations associated with thyroid cancer progression stages.
- Conceptualization of a stepwise molecular model for thyroid tumorigenesis.
Main Results:
- Thyroid cancer progression involves increased proliferation, decreased apoptosis, disrupted cell adhesion, and immortalization.
- Evidence suggests an evolutionary molecular process, particularly for follicular thyroid cancers with intermediate phenotypes.
- Key molecular events include oncogene activation and tumor suppressor inactivation.
Conclusions:
- A multi-step molecular progression model is proposed for thyroid cancer.
- This model aids in understanding the evolution of thyroid tumors.
- The proposed framework facilitates the integration of large-scale genomic findings into thyroid cancer research.